FI108037B - Menetelmä T-lymfasoluproteiinin valmistamiseksi, menetelmässä käytettävä ilmentämisväline, vektori ja isäntäsolu - Google Patents

Menetelmä T-lymfasoluproteiinin valmistamiseksi, menetelmässä käytettävä ilmentämisväline, vektori ja isäntäsolu Download PDF

Info

Publication number
FI108037B
FI108037B FI924575A FI924575A FI108037B FI 108037 B FI108037 B FI 108037B FI 924575 A FI924575 A FI 924575A FI 924575 A FI924575 A FI 924575A FI 108037 B FI108037 B FI 108037B
Authority
FI
Finland
Prior art keywords
cells
cell
gene
cdna
seq
Prior art date
Application number
FI924575A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI924575A0 (fi
FI924575A (fi
Inventor
Carol L Macleod
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of FI924575A0 publication Critical patent/FI924575A0/fi
Publication of FI924575A publication Critical patent/FI924575A/fi
Application granted granted Critical
Publication of FI108037B publication Critical patent/FI108037B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI924575A 1990-04-13 1992-10-09 Menetelmä T-lymfasoluproteiinin valmistamiseksi, menetelmässä käytettävä ilmentämisväline, vektori ja isäntäsolu FI108037B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50968490A 1990-04-13 1990-04-13
US50968490 1990-04-13
PCT/US1991/002518 WO1991016430A1 (en) 1990-04-13 1991-04-12 NOVEL T-CELL LYMPHOMA cDNA CLONES
US9102518 1991-04-12

Publications (3)

Publication Number Publication Date
FI924575A0 FI924575A0 (fi) 1992-10-09
FI924575A FI924575A (fi) 1992-10-09
FI108037B true FI108037B (fi) 2001-11-15

Family

ID=24027673

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924575A FI108037B (fi) 1990-04-13 1992-10-09 Menetelmä T-lymfasoluproteiinin valmistamiseksi, menetelmässä käytettävä ilmentämisväline, vektori ja isäntäsolu

Country Status (22)

Country Link
US (2) US5312733A (ar)
EP (1) EP0527813B1 (ar)
JP (1) JPH05506989A (ar)
KR (1) KR100212371B1 (ar)
AT (1) ATE141105T1 (ar)
AU (1) AU664535B2 (ar)
CA (1) CA2080018C (ar)
DE (1) DE69121240T2 (ar)
DK (1) DK0527813T3 (ar)
ES (1) ES2093100T3 (ar)
FI (1) FI108037B (ar)
GR (1) GR3021478T3 (ar)
HK (1) HK1006726A1 (ar)
IE (1) IE75903B1 (ar)
IL (1) IL97775A (ar)
NO (1) NO307341B1 (ar)
NZ (1) NZ237669A (ar)
PT (1) PT97355B (ar)
RU (1) RU2116346C1 (ar)
SA (1) SA92120348B1 (ar)
WO (1) WO1991016430A1 (ar)
ZA (1) ZA912489B (ar)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784163B1 (en) * 1990-04-13 2004-08-31 Macleod Carol L. Inhibition of cationic amino acid transporter protein and uses thereof
WO1994004567A1 (en) * 1992-08-21 1994-03-03 La Jolla Cancer Research Foundation A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids
WO1994026290A1 (en) * 1993-05-07 1994-11-24 Immunex Corporation Cytokine designated 4-1bb ligand and human receptor that binds thereto
US7138500B1 (en) 1993-05-07 2006-11-21 Immunex Corporation Antibodies to human 4-1BB
US7211259B1 (en) 1993-05-07 2007-05-01 Immunex Corporation 4-1BB polypeptides and DNA encoding 4-1BB polypeptides
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
AU6517800A (en) * 1999-08-04 2001-03-05 Amgen, Inc. Ntr3, a member of the tnf-receptor supergene family
US6521422B1 (en) * 1999-08-04 2003-02-18 Amgen Inc. Fhm, a novel member of the TNF ligand supergene family
AU2002364889A1 (en) * 2001-09-24 2003-06-10 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
EP1913401A4 (en) * 2005-08-03 2009-11-18 Astrazeneca Ab METHOD FOR IDENTIFYING AN AGENT THAT MODULATES TRANSPORTATION OF ARGININE IN A CHONDROCYTE
CA2629532C (en) 2005-11-18 2016-08-09 University Health Network Method of expanding double negative t cells
AU2010258094B2 (en) 2009-06-10 2013-09-05 Stephen Sanig Research Institute Ltd. Methods of generating cells exhibiting phenotypic plasticity

Also Published As

Publication number Publication date
JPH05506989A (ja) 1993-10-14
RU2116346C1 (ru) 1998-07-27
CA2080018C (en) 2003-10-14
PT97355A (pt) 1991-12-31
IL97775A0 (en) 1992-06-21
KR100212371B1 (ko) 1999-08-02
HK1006726A1 (en) 1999-03-12
AU7745791A (en) 1991-11-11
CA2080018A1 (en) 1991-10-14
US5440017A (en) 1995-08-08
EP0527813A1 (en) 1993-02-24
NO307341B1 (no) 2000-03-20
PT97355B (pt) 1998-08-31
ATE141105T1 (de) 1996-08-15
EP0527813A4 (en) 1993-05-05
FI924575A0 (fi) 1992-10-09
US5312733A (en) 1994-05-17
DE69121240T2 (de) 1997-01-09
IE911250A1 (en) 1991-10-23
NO923918L (no) 1992-12-01
NO923918D0 (no) 1992-10-08
ES2093100T3 (es) 1996-12-16
ZA912489B (en) 1992-01-29
IE75903B1 (en) 1997-10-08
GR3021478T3 (en) 1997-01-31
AU664535B2 (en) 1995-11-23
FI924575A (fi) 1992-10-09
IL97775A (en) 1998-04-05
EP0527813B1 (en) 1996-08-07
NZ237669A (en) 1992-08-26
DE69121240D1 (de) 1996-09-12
DK0527813T3 (da) 1996-12-30
SA92120348B1 (ar) 2004-01-24
KR930700657A (ko) 1993-03-15
WO1991016430A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
Krämer et al. Monoclonal antibody directed against RNA polymerase II of Drosophila melanogaster
FI108037B (fi) Menetelmä T-lymfasoluproteiinin valmistamiseksi, menetelmässä käytettävä ilmentämisväline, vektori ja isäntäsolu
JPH09512161A (ja) ヒトｔ（２；５）リンパ腫に存在する特異的融合核酸及びタンパク質、それらの検出方法及び用途
JPH03505964A (ja) ｎｅｕ遺伝子の発現及び遺伝子産物の検出
CA2065352A1 (en) Abo genotyping
JPH04507094A (ja) ネコｔ細胞リンパトロピック　レンチウィルスのポリペプチド
Devlin et al. Secretion of a soluble class I molecule encoded by the Q10 gene of the C57BL/10 mouse.
US4918162A (en) Assays and antibodies for N-MYC proteins
US5759803A (en) Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA
Bertoli et al. Bone marrow origin of a B-cell lymphoma
JP3779989B2 (ja) リンパ抗原ｃｄ３０
JP3445586B2 (ja) Ｄｎａプローブの開発およびヒト腫瘍関連抗原の免疫学的試薬
Ben-Nun et al. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
Doggett et al. Structure, origin, and transforming activity of feline leukemia virus-myc recombinant provirus FTT
EP0908466B1 (en) Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same
US6908750B2 (en) Gene encoding HM1.24 antigen protein and promoter thereof
Hollingsworth et al. Antigens expressed on NIH 3T3 cells following transformation with DNA from a human pancreatic tumor
EP0471825A1 (en) PTPase DIAGNOSTICS AND USES THEREOF
US20070141579A1 (en) MUM-1 protein expressed by multiple myeloma-related gene
Miescher et al. Selective expression of Vδ6 genes by B2A2− CD4− CD− T cell receptor γ/δ thymocytes
US20030040029A1 (en) Detection of tumor marker transcript and protein recognized by naive natural killer cells
Oudshoorn-Snoek et al. Identification and expression of the Tla region gene T11b and its Qa-like product.
US5763274A (en) Antibody 103B2
Lai et al. Human Retinoblastoma Susceptibility Gene
JPH11169171A (ja) 新規モノクローナル抗体およびその用途

Legal Events

Date Code Title Description
MA Patent expired